Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ningning Hou

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Frontiers in Public Health|October 27, 2022
The promotion of active aging through older adult education in the context of population agingKexin Zhang, Chengxia Kan, Youhong Luo, et al.
Lipids in Health and Disease|November 6, 2022
Irisin protects against obesity-related chronic kidney disease by regulating perirenal adipose tissue function in obese miceFang Han, Chengxia Kan, Di Wu, et al.
Menopause (New York, N.Y.)|May 5, 2026
Regional disparities and metabolic determinants of type 2 diabetes in women aged 55 and olderKexin Zhang, Chengxia Kan, Wei Xu, et al.
Lipids in Health and Disease|September 28, 2024
Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formationYouhong Luo, Tongtong Ye, Hongzhan Tian, et al.
Biochimie|April 5, 2023
Role of dysfunctional peri-organ adipose tissue in metabolic diseaseKexin Zhang, Jingwen Zhang, Chengxia Kan, et al.
Metabolic Syndrome and Related Disorders|December 30, 2025
Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic StrategiesXiaofei Zhang, Kexin Zhang, Yuqun Wang, et al.
Nutricion Hospitalaria|February 25, 2026
The effects of selenium supplementation on cardiovascular risk factors in patients with metabolic diseases ‒ A systematic review and meta-analysis of randomized controlled trialsWeixiu Qiu, Na Huang, Kexin Zhang, et al.
Digestive Diseases and Sciences|February 16, 2026
Epidemiological Trajectories and Quality of Care Disparities of MASLD in Asia, 1990-2023Kexin Zhang, Wei Xu, Chengxia Kan, et al.
Biochemical and Biophysical Research Communications|March 16, 2020
Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathwayXue Han, Chuanhua Ding, Guangdong Zhang, et al.
Kidney & Blood Pressure Research|January 8, 2026
Global Trends and Projections in Chronic Kidney Disease Burden from Diabetes, Hypertension, and Glomerulonephritis: A Population-Based StudyKexin Zhang, Chengxia Kan, Fang Han, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Frontiers in Public Health|October 27, 2022
The promotion of active aging through older adult education in the context of population agingKexin Zhang, Chengxia Kan, Youhong Luo, et al.
Lipids in Health and Disease|November 6, 2022
Irisin protects against obesity-related chronic kidney disease by regulating perirenal adipose tissue function in obese miceFang Han, Chengxia Kan, Di Wu, et al.
Menopause (New York, N.Y.)|May 5, 2026
Regional disparities and metabolic determinants of type 2 diabetes in women aged 55 and olderKexin Zhang, Chengxia Kan, Wei Xu, et al.
Lipids in Health and Disease|September 28, 2024
Empagliflozin alleviates obesity-related cardiac dysfunction via the activation of SIRT3-mediated autophagosome formationYouhong Luo, Tongtong Ye, Hongzhan Tian, et al.
Biochimie|April 5, 2023
Role of dysfunctional peri-organ adipose tissue in metabolic diseaseKexin Zhang, Jingwen Zhang, Chengxia Kan, et al.
Metabolic Syndrome and Related Disorders|December 30, 2025
Sterol Regulatory Element-Binding Proteins and Metabolic Diseases: Mechanisms, Implications, and Therapeutic StrategiesXiaofei Zhang, Kexin Zhang, Yuqun Wang, et al.
Nutricion Hospitalaria|February 25, 2026
The effects of selenium supplementation on cardiovascular risk factors in patients with metabolic diseases ‒ A systematic review and meta-analysis of randomized controlled trialsWeixiu Qiu, Na Huang, Kexin Zhang, et al.
Digestive Diseases and Sciences|February 16, 2026
Epidemiological Trajectories and Quality of Care Disparities of MASLD in Asia, 1990-2023Kexin Zhang, Wei Xu, Chengxia Kan, et al.
Biochemical and Biophysical Research Communications|March 16, 2020
Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathwayXue Han, Chuanhua Ding, Guangdong Zhang, et al.
Kidney & Blood Pressure Research|January 8, 2026
Global Trends and Projections in Chronic Kidney Disease Burden from Diabetes, Hypertension, and Glomerulonephritis: A Population-Based StudyKexin Zhang, Chengxia Kan, Fang Han, et al.
Pageof 9